Pacific Edge Limited Share Price and Company Fundamentals

0.040 (5.063%)
52 week
0.77 - 1.59

Last traded: Today at 5:00 AM

Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, Singapore, and internationally. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. It is also developing Cxbladder Resolve, a product designed to identify high grade or late stage bladder cancer and provide increased clinical resolution; Cxbladder Triage, a product that analyses the gene expression of urine-based biomarkers alongside information on known bladder cancer risk factors like age, gender, and smoking history to rule out patients with a low risk of having the disease; Cxbladder Detect that can be used as an adjunct to cystoscopy or as a substitute for other urine-based tests or imaging procedures; and Cxbladder Monitor, which is a non-invasive and easy-to-use test to rule out the return of bladder cancer. In addition, the company is developing Cxcolorectal (prognosis Gen II), a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancers; and products for bladder, gastric, colorectal, endometrial cancers, and melanoma. The company was incorporated in 2001 and is headquartered in Dunedin, New Zealand.

Key Metrics

PE ratio


PB ratio


Dividend yield




Market cap


Enterprise value


Company profile

Industry / SectorDiagnostics & Research / Healthcare
Mailing addressCentre for Innovation 87 St David Street PO Box 56 Dunedin 9016 New Zealand
Phone / Fax64 3 479 5800 / 64 3 479 5801


Dividend yield


Dividend amount


Payout ratio


Pacific Edge Limited paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.PEB dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

PEB's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of May 2022, following are the company executives and directors listed on Pacific Edge Limited.

NameTitleAgeTotal Pay
Dr. Peter MeintjesChief Exec. Officer
Mr. Grant GibsonChief Financial Officer
Ms. Demi StefanovaChief Operating Officer
Mr. Justin HarveyChief Technology Officer
Dr. Parry Guilford Ph.D.Chief Scientific Officer & Member of Scientific Advisory Board134k
Mr. Jack AtchasonSr. VP of Sales & Customer Service, Pacific Edge Diagnostics USA Limited
Mr. Andrew McIntoshChief of Information Systems & Decision Support
Ms. Jacqueline F. WalkerChief Exec. Officer of Pacific Edge Diagnostics USA
Mr. Tony LoughVP of Clinical Science & Product Performance, Pacific Edge Pty Limited
Mr. Brent PownallVP of Commercial & Franchise

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Pacific Edge Limited is and its enterprise value is .

The PEB's stocks Beta value is 0.89 making it 11% less volatile compared to NZX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Pacific Edge Limited (NZX:PEB) Frequently Asked Questions

1. What is Pacific Edge Limited's Stock Symbol?

Pacific Edge Limited trades on NZX under the ticker symbol "PEB".

2. What is Pacific Edge Limited's stock price today?

One share of PEB stock can currently be purchased for approximately $0.83.

3. How can I contact Pacific Edge Limited?

Pacific Edge Limited's mailing address is Centre for Innovation 87 St David Street PO Box 56 Dunedin 9016 New Zealand. The company can be reached via phone at 64 3 479 5800.

4. What is Pacific Edge Limited's official website?

The official website of Pacific Edge Limited is